查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1599693

miRNA 定序和分析市場：按產品和服務、技術、工作流程、最終用戶、應用分類 - 2025-2030 年全球預測

miRNA Sequencing & Assay Market by Product & Service (Products, Services), Technology (Nanopore Sequencing, Sanger Sequencing, Sequencing By Oligonucleotide Ligation & Detection), Workflow, End-User, Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年miRNA定序與分析市值為3.3335億美元，預計2024年將達到3.8021億美元，複合年成長率為14.15%，預計2030年將達到8.4192億美元。

調查方法miRNA 市場體現了旨在分析微型RNA的廣泛技術和方法，而 microRNA 是基因表現的重要調節因子。對 miRNA定序的需求源於其在理解癌症、心血管疾病和神經退化性疾病等疾病方面的潛在應用，為生物標記發現和個人化醫療提供了廣闊的前景。其最終用途包括學術研究機構、製藥公司、生物技術公司以及從事前沿研究的臨床實驗室。成長要素包括定序技術的進步，提高了準確性和成本效益，更加關注精準醫學中的基因組學，以及增加研究經費。最新的潛在機會在於對非侵入性診斷工具不斷成長的需求，這些工具能夠透過液態切片早期發現疾病。公司應利用與研究機構的夥伴關係來加速創新並利用人們對 RNA 療法日益成長的興趣。然而，市場面臨諸如測序儀和檢測的高成本、資料解釋的複雜性以及監管挑戰等限制。此外，還存在資料分析變化和缺乏標準化通訊協定等挑戰，需要解決這些挑戰才能廣泛使用。最佳創新領域包括開發價格實惠且易於使用的定序平台、透過人工智慧整合改進資料分析工具以更好地解釋，以及擴展 miRNA 功能的綜合資料庫。與監管機構的合作將有助於制定標準並解決合規問題。 miRNA 定序和檢測市場的本質是動態的，受到技術進步和對精準醫療解決方案不斷成長的需求的推動。那些能夠適應監管環境、投資研發以降低成本以及加深對 miRNA 在各種疾病中作用的了解的公司，將處於有利地位，並能夠保持長期成長和影響力。專注於提高科學家在 miRNA 技術和資料分析方面的技能的培訓計劃可以進一步推動市場擴張和創新。

主要市場統計
基準年[2023] 33335萬美元
預測年份 [2024] 38021萬美元
預測年份 [2030] 84192萬美元
複合年成長率（%） 14.15%

市場動態：揭示快速發展的 miRNA 定序和分析市場的關鍵市場洞察

供需的動態交互作用正在改變 miRNA 定序和檢測市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 評估 miRNA 序列的各種技術簡介
    • 感染疾病流行率不斷上升
    • 癌症病例數迅速增加
  • 市場限制因素
    • 缺乏熟練的專業人員
  • 市場機會
    • 具成本效益的定序技術日益普及
    • 遺傳學領域研究數量的增加
  • 市場挑戰
    • 基礎建設初始投資高

波特五力：引領 miRNA 定序與檢測市場的策略工具

波特的「五力」框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解 miRNA 定序和檢測市場的外部影響

外部宏觀環境因素在塑造 miRNA 定序和分析市場的績效動態方面發揮關鍵作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解 miRNA 定序和檢測市場的競爭格局

對 miRNA 定序和分析市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來發現自己的競爭定位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣 miRNA 定序與分析市場供應商的績效評估

FPNV 定位矩陣是評估 miRNA 定序和分析市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議繪製 miRNA 定序和檢測市場的成功之路

對於想要加強在全球市場的影響力的公司來說，對 miRNA 定序和檢測市場進行策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 評估 miRNA 序列的各種技術簡介
      • 感染疾病傳播加劇
      • 癌症發生率迅速增加
    • 抑制因素
      • 缺乏熟練的專業人員
    • 機會
      • 具有成本效益的定序技術越來越受歡迎
      • 遺傳學領域研究數量的增加
    • 任務
      • 基礎建設初期投資較高
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第 6 章 miRNA 定序與分析市場：依產品和服務分類

  • 產品
    • 裝置
    • 文庫製備試劑套件
    • 定序耗材
  • 服務

第 7 章 miRNA 定序與分析市場：依技術分類

  • 奈米孔定序
  • 桑格序列
  • 透過寡核苷酸連接和檢測定序
  • 單分子即時 (SMRT)定序

第 8 章 miRNA 定序與檢測市場：按工作流程

  • 資料分析與存儲
  • 準備圖書館
  • 定序

第 9 章 miRNA 定序與分析市場：依最終使用者分類

  • 合約調查機構
  • 製藥和生物技術產業
  • 研究/學術機構

第 10 章 miRNA 定序與分析市場：按應用分類

  • 自體免疫疾病
  • 癌症
  • 多聚谷氨醯胺病
  • 思覺失調症

第11章美洲 miRNA 定序與分析市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第12章亞太地區miRNA定序與分析市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第13章歐洲、中東和非洲的miRNA定序與檢測市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Abcam PLC
  • Bio-Rad Laboratories, Inc.
  • Global Life Sciences Solutions USA LLC
  • HTG Molecular Diagnostics, Inc.
  • Illumina, Inc.
  • Integrated DNA Technologies, Inc
  • Lexogen GmbH
  • Meridian Bioscience Inc
  • New England Biolabs（UK）Ltd.
  • Norgen Biotek Corp.
  • Oxford Nanopore Technologies Limited
  • Rosetta Genomics Ltd.
  • Sigma Aldrich Corp.
  • System Biosciences, LLC
  • Thermo Fisher Scientific Inc.
  • TriLink BioTechnologies, Inc.
Product Code: MRR-0A609A26A984

The miRNA Sequencing & Assay Market was valued at USD 333.35 million in 2023, expected to reach USD 380.21 million in 2024, and is projected to grow at a CAGR of 14.15%, to USD 841.92 million by 2030.

The miRNA Sequencing & Assay market embodies the expansive scope of technologies and methodologies designed to analyze microRNAs, critical regulators of gene expression. The necessity of miRNA sequencing arises from its potential applications in understanding diseases, including cancer, cardiovascular, and neurodegenerative disorders, offering significant prospects for biomarker discovery and personalized medicine. Its end-use scope spans academic research institutions, pharmaceutical and biotechnological companies, and clinical laboratories engaged in cutting-edge research. Influencing growth factors include advancements in sequencing technologies that enhance accuracy and cost-effectiveness, a rising focus on genomics in precision medicine, and expanded research funding. Latest potential opportunities lie in the increasing demand for non-invasive diagnostic tools, enabling early disease detection through liquid biopsies. Companies should exploit partnerships with research institutes to fast-track innovation and capitalize on the rising interest in RNA therapeutics. However, the market faces limitations from the high cost of sequencers and assays, the complexity of data interpretation, and regulatory challenges. Additionally, variability in data analysis and a lack of standardized protocols present challenges that require resolution for more widespread adoption. The best areas for innovation include developing affordable and user-friendly sequencing platforms, improving data analytics tools with AI integration for better interpretation, and expanding comprehensive databases for miRNA function. Collaborations with regulatory agencies could aid in establishing standards and addressing compliance concerns. The nature of the miRNA Sequencing & Assay market is dynamic, driven by technological advancement and the escalating demand for precision healthcare solutions. Companies that can navigate regulatory landscapes, invest in R&D to reduce costs, and broaden the understanding of miRNA's role in various conditions are well-positioned to sustain long-term growth and impact. Enhanced focus on training programs to skill scientists in miRNA technologies and data analysis can further catalyze market expansion and innovation.

KEY MARKET STATISTICS
Base Year [2023] USD 333.35 million
Estimated Year [2024] USD 380.21 million
Forecast Year [2030] USD 841.92 million
CAGR (%) 14.15%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving miRNA Sequencing & Assay Market

The miRNA Sequencing & Assay Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Introduction of various techniques to assess the miRNA sequence
    • Increased prevalence of infectious diseases
    • Surge in the number of cancer incidences
  • Market Restraints
    • Lack of skilled professionals
  • Market Opportunities
    • Growing popularity for cost effective sequencing techniques
    • Increase in the number of research in genetic segment
  • Market Challenges
    • High initial investment on infrastructure

Porter's Five Forces: A Strategic Tool for Navigating the miRNA Sequencing & Assay Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the miRNA Sequencing & Assay Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the miRNA Sequencing & Assay Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the miRNA Sequencing & Assay Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the miRNA Sequencing & Assay Market

A detailed market share analysis in the miRNA Sequencing & Assay Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the miRNA Sequencing & Assay Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the miRNA Sequencing & Assay Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the miRNA Sequencing & Assay Market

A strategic analysis of the miRNA Sequencing & Assay Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the miRNA Sequencing & Assay Market, highlighting leading vendors and their innovative profiles. These include Abcam PLC, Bio-Rad Laboratories, Inc., Global Life Sciences Solutions USA LLC, HTG Molecular Diagnostics, Inc., Illumina, Inc., Integrated DNA Technologies, Inc, Lexogen GmbH, Meridian Bioscience Inc, New England Biolabs (UK) Ltd., Norgen Biotek Corp., Oxford Nanopore Technologies Limited, Rosetta Genomics Ltd., Sigma Aldrich Corp., System Biosciences, LLC, Thermo Fisher Scientific Inc., and TriLink BioTechnologies, Inc..

Market Segmentation & Coverage

This research report categorizes the miRNA Sequencing & Assay Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product & Service, market is studied across Products and Services. The Products is further studied across Instruments, Library Preparation Kits, and Sequencing Consumables.
  • Based on Technology, market is studied across Nanopore Sequencing, Sanger Sequencing, Sequencing By Oligonucleotide Ligation & Detection, and Single Molecule Real-Time (SMRT) Sequencing.
  • Based on Workflow, market is studied across Data Analysis & Storage, Library Preparation, and Sequencing.
  • Based on End-User, market is studied across Contract Research Organizations, Pharmaceutical & Biotechnology Industry, and Research & Academic Institutes.
  • Based on Application, market is studied across Autoimmune Disease, Cancer, Polyglutamine Diseases, and Schizophrenia.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Introduction of various techniques to assess the miRNA sequence
      • 5.1.1.2. Increased prevalence of infectious diseases
      • 5.1.1.3. Surge in the number of cancer incidences
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of skilled professionals
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing popularity for cost effective sequencing techniques
      • 5.1.3.2. Increase in the number of research in genetic segment
    • 5.1.4. Challenges
      • 5.1.4.1. High initial investment on infrastructure
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. miRNA Sequencing & Assay Market, by Product & Service

  • 6.1. Introduction
  • 6.2. Products
    • 6.2.1. Instruments
    • 6.2.2. Library Preparation Kits
    • 6.2.3. Sequencing Consumables
  • 6.3. Services

7. miRNA Sequencing & Assay Market, by Technology

  • 7.1. Introduction
  • 7.2. Nanopore Sequencing
  • 7.3. Sanger Sequencing
  • 7.4. Sequencing By Oligonucleotide Ligation & Detection
  • 7.5. Single Molecule Real-Time (SMRT) Sequencing

8. miRNA Sequencing & Assay Market, by Workflow

  • 8.1. Introduction
  • 8.2. Data Analysis & Storage
  • 8.3. Library Preparation
  • 8.4. Sequencing

9. miRNA Sequencing & Assay Market, by End-User

  • 9.1. Introduction
  • 9.2. Contract Research Organizations
  • 9.3. Pharmaceutical & Biotechnology Industry
  • 9.4. Research & Academic Institutes

10. miRNA Sequencing & Assay Market, by Application

  • 10.1. Introduction
  • 10.2. Autoimmune Disease
  • 10.3. Cancer
  • 10.4. Polyglutamine Diseases
  • 10.5. Schizophrenia

11. Americas miRNA Sequencing & Assay Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific miRNA Sequencing & Assay Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa miRNA Sequencing & Assay Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abcam PLC
  • 2. Bio-Rad Laboratories, Inc.
  • 3. Global Life Sciences Solutions USA LLC
  • 4. HTG Molecular Diagnostics, Inc.
  • 5. Illumina, Inc.
  • 6. Integrated DNA Technologies, Inc
  • 7. Lexogen GmbH
  • 8. Meridian Bioscience Inc
  • 9. New England Biolabs (UK) Ltd.
  • 10. Norgen Biotek Corp.
  • 11. Oxford Nanopore Technologies Limited
  • 12. Rosetta Genomics Ltd.
  • 13. Sigma Aldrich Corp.
  • 14. System Biosciences, LLC
  • 15. Thermo Fisher Scientific Inc.
  • 16. TriLink BioTechnologies, Inc.

LIST OF FIGURES

  • FIGURE 1. MIRNA SEQUENCING & ASSAY MARKET RESEARCH PROCESS
  • FIGURE 2. MIRNA SEQUENCING & ASSAY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS MIRNA SEQUENCING & ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS MIRNA SEQUENCING & ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES MIRNA SEQUENCING & ASSAY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES MIRNA SEQUENCING & ASSAY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC MIRNA SEQUENCING & ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC MIRNA SEQUENCING & ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. MIRNA SEQUENCING & ASSAY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. MIRNA SEQUENCING & ASSAY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. MIRNA SEQUENCING & ASSAY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. MIRNA SEQUENCING & ASSAY MARKET DYNAMICS
  • TABLE 7. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY LIBRARY PREPARATION KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SEQUENCING CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY NANOPORE SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SANGER SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SEQUENCING BY OLIGONUCLEOTIDE LIGATION & DETECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SINGLE MOLECULE REAL-TIME (SMRT) SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY DATA ANALYSIS & STORAGE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY LIBRARY PREPARATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY INDUSTRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY AUTOIMMUNE DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY POLYGLUTAMINE DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SCHIZOPHRENIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS MIRNA SEQUENCING & ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 52. CANADA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 55. CANADA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. CANADA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. MEXICO MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 58. MEXICO MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 59. MEXICO MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 60. MEXICO MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 61. MEXICO MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. MEXICO MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. UNITED STATES MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 66. UNITED STATES MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 67. UNITED STATES MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. UNITED STATES MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. UNITED STATES MIRNA SEQUENCING & ASSAY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC MIRNA SEQUENCING & ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 78. AUSTRALIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 79. AUSTRALIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 80. AUSTRALIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 81. AUSTRALIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. AUSTRALIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. CHINA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 84. CHINA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 85. CHINA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 86. CHINA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 87. CHINA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. CHINA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. INDIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 90. INDIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 91. INDIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 92. INDIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 93. INDIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. INDIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. INDONESIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 96. INDONESIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 97. INDONESIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 98. INDONESIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 99. INDONESIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. INDONESIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. JAPAN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 102. JAPAN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 103. JAPAN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 104. JAPAN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 105. JAPAN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. JAPAN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. MALAYSIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 108. MALAYSIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 109. MALAYSIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 110. MALAYSIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 111. MALAYSIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. MALAYSIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. PHILIPPINES MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 114. PHILIPPINES MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 115. PHILIPPINES MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 116. PHILIPPINES MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 117. PHILIPPINES MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. PHILIPPINES MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. SINGAPORE MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 120. SINGAPORE MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 121. SINGAPORE MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 122. SINGAPORE MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 123. SINGAPORE MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. SINGAPORE MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH KOREA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH KOREA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH KOREA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH KOREA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH KOREA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH KOREA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. TAIWAN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 132. TAIWAN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 133. TAIWAN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 134. TAIWAN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 135. TAIWAN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. TAIWAN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. THAILAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 138. THAILAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 139. THAILAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 140. THAILAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 141. THAILAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. THAILAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. VIETNAM MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 144. VIETNAM MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 145. VIETNAM MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 146. VIETNAM MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 147. VIETNAM MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 148. VIETNAM MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 156. DENMARK MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 157. DENMARK MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 158. DENMARK MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 159. DENMARK MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 160. DENMARK MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 161. DENMARK MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. EGYPT MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 163. EGYPT MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 164. EGYPT MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 165. EGYPT MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 166. EGYPT MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 167. EGYPT MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. FINLAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 169. FINLAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 170. FINLAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 171. FINLAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 172. FINLAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 173. FINLAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. FRANCE MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 175. FRANCE MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 176. FRANCE MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 177. FRANCE MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 178. FRANCE MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 179. FRANCE MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. GERMANY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 181. GERMANY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 182. GERMANY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 183. GERMANY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 184. GERMANY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 185. GERMANY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. ISRAEL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 187. ISRAEL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 188. ISRAEL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 189. ISRAEL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 190. ISRAEL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 191. ISRAEL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 192. ITALY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 193. ITALY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 194. ITALY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 195. ITALY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 196. ITALY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 197. ITALY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 198. NETHERLANDS MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 199. NETHERLANDS MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 200. NETHERLANDS MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 201. NETHERLANDS MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 202. NETHERLANDS MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 203. NETHERLANDS MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 204. NIGERIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 205. NIGERIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 206. NIGERIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 207. NIGERIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 208. NIGERIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 209. NIGERIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 210. NORWAY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 211. NORWAY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 212. NORWAY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 213. NORWAY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 214. NORWAY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 215. NORWAY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 216. POLAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 217. POLAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 218. POLAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 219. POLAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 220. POLAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 221. POLAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 222. QATAR MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 223. QATAR MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 224. QATAR MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 225. QATAR MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 226. QATAR MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 227. QATAR MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 228. RUSSIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 229. RUSSIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 230. RUSSIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 231. RUSSIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 232. RUSSIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 233. RUSSIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 234. SAUDI ARABIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 235. SAUDI ARABIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 236. SAUDI ARABIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 237. SAUDI ARABIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 238. SAUDI ARABIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 239. SAUDI ARABIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 240. SOUTH AFRICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 241. SOUTH AFRICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 242. SOUTH AFRICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 243. SOUTH AFRICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 244. SOUTH AFRICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 245. SOUTH AFRICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 246. SPAIN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 247. SPAIN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 248. SPAIN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 249. SPAIN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 250. SPAIN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 251. SPAIN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 252. SWEDEN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 253. SWEDEN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 254. SWEDEN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 255. SWEDEN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 256. SWEDEN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 257. SWEDEN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 258. SWITZERLAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 259. SWITZERLAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 260. SWITZERLAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 261. SWITZERLAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 262. SWITZERLAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 263. SWITZERLAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 264. TURKEY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 265. TURKEY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 266. TURKEY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 267. TURKEY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 268. TURKEY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 269. TURKEY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 270. UNITED ARAB EMIRATES MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 271. UNITED ARAB EMIRATES MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 272. UNITED ARAB EMIRATES MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED ARAB EMIRATES MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED ARAB EMIRATES MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED ARAB EMIRATES MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED KINGDOM MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED KINGDOM MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 278. UNITED KINGDOM MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 279. UNITED KINGDOM MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 280. UNITED KINGDOM MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 281. UNITED KINGDOM MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 282. MIRNA SEQUENCING & ASSAY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 283. MIRNA SEQUENCING & ASSAY MARKET, FPNV POSITIONING MATRIX, 2023